Core Viewpoint - *ST Sailong (002898.SZ) has recently received approval from the National Medical Products Administration for the marketing authorization of magnesium aspartate and potassium aspartate, which are essential for producing electrolyte replenishment medications [1] Group 1 - The company’s wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., has been granted the marketing authorization for magnesium aspartate and potassium aspartate [1] - The approved chemical raw materials can be used to produce aspartate potassium injection and aspartate magnesium injection formulations [1] - These products are classified as electrolyte replenishment drugs, indicating their importance in medical treatments [1]